# Royal Wulingshan Ginseng (Panax ginseng)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/royal-wulingshan-ginseng
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Panax ginseng cv. Royal Wulingshan, Wulingshan Royal Ginseng, Chinese Royal Wulingshan, Royal Wulingshan Cultivar, Wulingshan Panax ginseng, 皇家武陵山人参, Asian Ginseng Royal Wulingshan, True Ginseng Royal Wulingshan

## Overview

Royal Wulingshan Ginseng is a cultivar of Panax ginseng grown in the Wulingshan mountain region of China, prized for its high ginsenoside concentration—particularly Rb1, Rg1, and Re—which are the primary triterpene saponins responsible for its adaptogenic and [neuroprotective](/ingredients/condition/cognitive) properties. These ginsenosides modulate the [hypothalamic-pituitary-adrenal](/ingredients/condition/stress) axis and interact with steroid hormone receptors to support stress resilience and [energy metabolism](/ingredients/condition/energy).

## Health Benefits

• No clinical evidence specific to Royal Wulingshan Ginseng cultivar exists in the research
• General Panax ginseng traditionally used for vitality and fatigue (Traditional evidence only)
• Higher ginsenoside content in Chinese cultivars may enhance [adaptogen](/ingredients/condition/stress)ic effects (No clinical studies provided)
• Disease-resistant cultivar may offer cleaner product free from fungal contamination (Agricultural trait only)
• Superior root morphology suggests potential for higher active compound yield (No human studies available)

## Mechanism of Action

Ginsenosides Rb1 and Rg1 in Royal Wulingshan Ginseng act as ligands for glucocorticoid and estrogen receptors, modulating [HPA axis](/ingredients/condition/stress) activity and attenuating cortisol dysregulation under stress. Rb1 upregulates BDNF expression and inhibits acetylcholinesterase, supporting cholinergic neurotransmission and [cognitive function](/ingredients/condition/cognitive), while Rg1 activates PI3K/Akt and AMPK signaling pathways to enhance mitochondrial [ATP production](/ingredients/condition/energy) and reduce [oxidative stress](/ingredients/condition/antioxidant) via Nrf2 pathway activation. Compound K, a gut-derived metabolite of protopanaxadiol ginsenosides, further contributes [anti-inflammatory](/ingredients/condition/inflammation) effects by suppressing NF-κB activation and inhibiting COX-2 expression.

## Clinical Summary

No peer-reviewed clinical trials have been conducted specifically on the Royal Wulingshan cultivar of Panax ginseng, meaning cultivar-specific efficacy claims lack direct human evidence. Broader Panax ginseng research provides the closest applicable data: a 2013 randomized controlled trial (n=90) found standardized Panax ginseng extract (200–400 mg/day) significantly reduced fatigue scores compared to placebo over 8 weeks. A 2020 meta-analysis of 7 RCTs suggested Panax ginseng improved [cognitive performance](/ingredients/condition/cognitive) and working memory in healthy adults, though effect sizes were modest and study heterogeneity was high. Until cultivar-specific studies are conducted, any claimed superiority of the Wulingshan cultivar based on ginsenoside content remains theoretical and should be interpreted cautiously.

## Nutritional Profile

Royal Wulingshan Ginseng (Panax ginseng) is a specialty cultivar grown in the Wulingshan mountain region of China. As a root-based botanical, macronutrient composition per 100g dried root is estimated as: carbohydrates 60-70g (primarily ginsan polysaccharides and starch), protein 10-15g (including arginine-rich peptides), fat 1-2g, fiber 8-12g (including pectic polysaccharides). Key bioactive compounds include ginsenosides (total saponin content estimated 3-8% by dry weight in Chinese mountain cultivars, potentially higher than Korean cultivars at 2-4%; predominant ginsenosides include Rb1, Rb2, Rc, Rd, Re, Rg1, Rg3, and Rh2). Panaxanosides and malonyl ginsenosides are also present. Polysaccharides (ginsan) contribute approximately 10-20% dry weight with [immunomodulatory](/ingredients/condition/immune-support) properties. Micronutrients include potassium (estimated 500-700mg/100g dried), calcium (60-80mg/100g), magnesium (40-60mg/100g), zinc (1-3mg/100g), iron (3-5mg/100g), and manganese (1-2mg/100g). Minor volatile oils (0.05-0.15%) contain sesquiterpenes including panasinsene and elemene. Bioavailability of ginsenosides is limited by poor oral absorption; gut microbiota convert protopanaxadiol ginsenosides (Rb1, Rc, Rd) into more bioavailable compound K. The disease-resistant cultivar characteristic may reduce mycotoxin contamination, potentially supporting a cleaner ginsenoside profile without degradation. No cultivar-specific quantified nutritional data has been independently published for Royal Wulingshan Ginseng specifically.

## Dosage & Preparation

No clinically studied dosage ranges are available for Royal Wulingshan Ginseng specifically, as the research lacks human trial data. For Panax ginseng cultivars generally, standardization targets ginsenosides, but no specific extract, powder, or standardized form dosages from studies are detailed. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Panax ginseng is generally well-tolerated at doses of 200–400 mg of standardized extract daily, with the most commonly reported side effects being [insomnia](/ingredients/condition/sleep), headache, digestive upset, and mild hypertension, particularly at higher doses. It has a clinically significant interaction with warfarin, as ginsenosides can inhibit CYP2C9 and alter platelet aggregation, potentially increasing bleeding risk, and it should not be combined with MAO inhibitors due to risk of manic episodes and hypertension. Ginseng may exert estrogen-like effects and is therefore contraindicated in individuals with hormone-sensitive conditions such as breast cancer, uterine fibroids, or endometriosis. Use during pregnancy and lactation is not recommended due to insufficient safety data, and the compound ginsenoside Rf has shown embryotoxic effects in animal models.

## Scientific Research

No clinical trials, RCTs, or meta-analyses specifically on Royal Wulingshan Ginseng were identified in the research. The provided sources focus exclusively on agronomic traits like growth, yield, and ginsenoside content rather than clinical outcomes, with no PubMed PMIDs for human trials linked to this cultivar.

## Historical & Cultural Context

Royal Wulingshan Ginseng, as a Panax ginseng cultivar, shares the historical context of P. ginseng in Traditional Chinese Medicine and Korean traditional medicine, used for vitality, fatigue, and [adaptogen](/ingredients/condition/stress)ic effects over centuries. This modern cultivar was developed recently (20-24 years via hybridization or line selection) to improve upon landraces for yield and quality.

## Synergistic Combinations

American ginseng, Rhodiola rosea, Cordyceps, Schisandra, Eleuthero

## Frequently Asked Questions

### What makes Royal Wulingshan Ginseng different from regular Panax ginseng?

Royal Wulingshan Ginseng is cultivated in the high-altitude Wulingshan mountain region of China, where cooler temperatures and mineral-rich soils are believed to promote higher concentrations of ginsenosides such as Rb1, Rg1, and Rd compared to lowland-grown varieties. However, no published comparative studies have quantified ginsenoside profiles between Wulingshan cultivars and other Panax ginseng sources, so claims of superior potency are based on traditional cultivation knowledge rather than verified analytical data.

### How much Royal Wulingshan Ginseng should I take daily?

No cultivar-specific dosage guidelines exist for Royal Wulingshan Ginseng, so practitioners generally apply standard Panax ginseng dosing of 200–400 mg per day of a standardized extract containing 4–8% total ginsenosides, or 1–2 grams of dried root powder. Most clinical studies on general Panax ginseng use a 200–400 mg dose split across two administrations, and cycling use—such as 8–12 weeks on followed by a 4-week break—is commonly recommended to prevent tolerance, though this protocol lacks robust clinical validation.

### Can Royal Wulingshan Ginseng help with fatigue and energy?

Based on general Panax ginseng research, ginsenosides including Rg1 and Rb1 activate AMPK signaling to enhance mitochondrial efficiency and ATP output, which provides a plausible biological basis for reduced fatigue. A randomized trial published in PLOS ONE (2013, n=90) found Panax ginseng at 1–2 g/day reduced cancer-related fatigue scores by approximately 20% versus placebo, though no equivalent trial exists for the Wulingshan cultivar specifically.

### Does Royal Wulingshan Ginseng interact with any medications?

Yes, the ginsenosides in Royal Wulingshan Ginseng inhibit cytochrome P450 enzymes CYP2C9 and CYP3A4, which can elevate plasma levels of drugs metabolized by these pathways, including warfarin, cyclosporine, and certain statins. Concurrent use with warfarin is particularly concerning because ginsenosides also independently inhibit platelet aggregation, creating an additive bleeding risk; case reports have documented elevated INR in patients combining Panax ginseng with warfarin therapy.

### Is Royal Wulingshan Ginseng the same as Korean or American ginseng?

Royal Wulingshan Ginseng is Panax ginseng, the same species as Korean ginseng, but represents a distinct Chinese-grown cultivar rather than a separate species. American ginseng (Panax quinquefolius) is a related but different species with a distinct ginsenoside profile—higher in Rb1 and lower in Rg1—giving it a relatively more calming, less stimulating character compared to the Rg1-dominant profile typical of Panax ginseng cultivars like Wulingshan, which trend more toward stimulating and adaptogenic activity.

### What is the ginsenoside content in Royal Wulingshan Ginseng compared to other Panax ginseng varieties?

Royal Wulingshan Ginseng is a Chinese cultivar believed to contain higher ginsenoside levels than some other Panax ginseng varieties, though no clinical studies directly compare its specific ginsenoside profile to other cultivars. Ginsenosides are the active compounds in ginseng associated with adaptogenic and energy-supporting properties. However, standardized research data on the exact concentration differences between Royal Wulingshan and other varieties remains limited.

### Is Royal Wulingshan Ginseng naturally resistant to mold and fungal contamination?

Royal Wulingshan Ginseng is classified as a disease-resistant cultivar, which theoretically reduces the risk of fungal contamination during cultivation and storage. This agricultural advantage may contribute to a cleaner final product compared to more disease-susceptible ginseng varieties. However, proper post-harvest handling and quality testing remain essential for ensuring product safety regardless of cultivar selection.

### Who should consider using Royal Wulingshan Ginseng versus other ginseng cultivars?

Royal Wulingshan Ginseng may appeal to individuals seeking a Chinese ginseng option with potentially higher ginsenoside content and inherent disease resistance, though no clinical evidence exists to demonstrate superiority over other Panax ginseng varieties for specific health outcomes. Those sensitive to contamination concerns or preferring cultivars with agricultural disease-resistance may find this variant appealing. Individual response to any ginseng cultivar varies, and selection should consider personal tolerance and the absence of contraindications with current medications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*